Arcus Biosciences, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
261.59 |
121.64 |
150.50 |
229.36 |
503.01 |
881.36 |
| Przychód Δ r/r |
0.00% |
-53.50% |
23.72% |
52.40% |
119.31% |
75.22% |
| Przychód (min) |
246.95 |
24.99 |
39.26 |
223.88 |
183.93 |
322.28 |
| Przychód (max) |
272.26 |
261.97 |
253.12 |
234.85 |
907.91 |
1,590.83 |
| EBITDA (średnia) |
-200.80 |
-93.38 |
-115.53 |
-176.07 |
-386.12 |
-676.56 |
| EBIT (średnia) |
-201.77 |
-93.82 |
-116.08 |
-176.91 |
-387.98 |
-679.81 |
| EBIT % |
-77.13% |
-77.13% |
-77.13% |
-77.13% |
-77.13% |
-77.13% |
| Zysk netto (średni) |
-304.93 |
-415.80 |
-451.34 |
-440.87 |
-142.06 |
55.22 |
| Zysk netto % |
-116.57% |
-341.83% |
-299.90% |
-192.22% |
-28.24% |
6.26% |
| EPS (średnia) |
-3.41 |
-4.61 |
-4.49 |
-3.75 |
-1.58 |
0.61 |
| Liczba analityków (Przychody) |
7 |
7 |
10 |
9 |
3 |
4 |
| Liczba analityków (EPS) |
6 |
5 |
6 |
7 |
5 |
2 |
| symbol |
RCUS |
RCUS |
RCUS |
RCUS |
RCUS |
RCUS |